Abstract
To the Editor: Valdecoxib, a cyclo-oxygenase-2 inhibitor, is generally well tolerated although severe cutaneous adverse reactions have been reported to the manufacturer early in the postmarketing phase of this drug. We report two patients who developed fever, malaise, and an unusual purpuric eruption associated with valdecoxib use.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
